We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byChristopher Ryan
Modified over 3 years ago
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American Heart Association Get With the Guidelines Program Pamela N. Peterson, MD, MSPH; John S. Rumsfeld, MD, PhD; Li Liang, PhD; Nancy M. Albert, RN, PhD; Adrian F. Hernandez, MD, MHS; Eric D. Peterson, MD, MPH; Gregg C. Fonarow, MD; Frederick A Masoudi, MD, MSPH
© 2010, American Heart Association. All rights reserved. Background HF is a common reason for hospitalization in the United States and a tremendous economic burden. Physicians often miss opportunities to improve the quality of care for their patients hospitalized with HF because they do not calibrate HF therapy to a patients risk for adverse outcomes. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32.
© 2010, American Heart Association. All rights reserved. Introduction Risk models may be useful in predicting in-hospital mortality. Patients hospitalized with heart failure (HF) provide a unique setting for the validation of such prognostic information collection. The Get With The Guidelines--HF (GWTG-HF) programs validated risk score has the potential to influence the quality of care provided to patients hospitalized with HF by informing decision making through routinely collected clinical data. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32.
© 2010, American Heart Association. All rights reserved. Objective The purpose of this study was to derive and validate a predictive model for in-hospital mortality using readily available clinical data in patients with HF admitted to a GWTG-HF hospital. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32
© 2010, American Heart Association. All rights reserved. Methods Between January 2005 and June 2007, data were collected from a cohort of 39,783 patients admitted to 198 GWTG-HF participating hospitals. Potential predictor variables included demo- graphics, co-morbidities, admission laboratory information, vital signs at presentation, and LV systolic dysfunction of 40%. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32.
© 2010, American Heart Association. All rights reserved. Results In-hospital death occurred in 1139 (2.86%) patients. Those who died were more likely to have a prior HF diagnosis and an LVEF < 40%, atrial fibrillation, CAD, COPD, anemia and renal insufficiency, higher heart rates, serum creatinine and BUN levels and lower blood pressure, serum sodium and hemoglobin levels on admission, but less likely to have hypertension, hyperlipidemia, or diabetes. Age, systolic blood pressure, BUN level, serum sodium, and heart rate on admission, non--Black race and the presence of COPD were independent predictors of in-hospital death. No significant interactions between left ventricular systolic function and coexisting illnesses were present, indicating that the impact of individual risk factors on outcome was consistent regardless of left ventricular function. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32
© 2010, American Heart Association. All rights reserved. Conclusions Age, systolic blood pressure, and BUN level are the admission variables most predictive of in-hospital mortality, with admission heart rate, serum sodium, presence of COPD, and non--Black race contributing modestly. The validated GWTG-HF risk score uses routinely collected data to predict the risk of in-hospital mortality for patients hospitalized with HF. Application of the risk score derived from routine clinical factors collected at the time of admission could influence the quality of care provided to patients hospitalized with HF by informing clinical decision making. Peterson et al. Circulation: Cardiovascular Quality and Outcomes. 2010;3:25-32
Treatment and Risk in Heart Failure: Gaps in Evidence or Quality? Pamela N. Peterson, MD MSPH; John S. Rumsfeld, MD PhD; Li Liang PhD; Adrian F. Hernandez,
© 2010, American Heart Association. All rights reserved. Evolving Patterns of Use and Appropriateness of Aldosterone Antagonists in Heart Failure Nancy.
“Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure (GWTG-HF)” Daniel E. Forman, MD; Christopher.
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
© 2010, American Heart Association. All rights reserved. Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
Quality of Care and In-Hospital Outcomes in Patients With Coronary Heart Disease in Rural and Urban Hospitals (from Get With the Guidelines– Coronary.
Predictors of Cardiac Rehabilitation Referral in Coronary Artery Disease Patients: Results From the AHA’s Get With the Guidelines Program Todd M. Brown,
Schwamm et al. Circulation epub April 6Schwamm et al. Race/Ethnicity, Quality of Care, and Outcomes in Ischemic Stroke Lee H. Schwamm, MD; Mathew.
Hernandez et al. JAMA, May 5, 2010 – Vol. 303, No. 17 Relationship Between Early Physician Follow-up and 30-day Readmission Among Medicare Beneficiaries.
The Relationship Between CMS Quality Indicators and Long-term Outcomes Among Hospitalized Heart Failure Patients Mark Patterson, Ph.D., M.P.H. Post-doctoral.
Influence of Age on the Management of Heart Failure: Findings from Get With the Guidelines-HF DE Forman, CP Cannon, AF Hernandez, L Liang, CW Yancy, GC.
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
Are Quality Improvements Associated with the GWTG-Coronary Artery Disease (GWTG-CAD) Program Sustained Over Time? A Longitudinal Comparison of GWTG-CAD.
“Influence of Stroke Subtype on Quality of Care in The Get With The Guidelines-Stroke Program” Eric E. Smith, MD, MPH; Li Liang PhD; Adrian F Hernandez,
Evolving Patterns Of Use Of Aldosterone Inhibition In Chronic Heart Failure; A Report From Get With The Guidelines HF Nancy M. Albert, Clyde W. Yancy,
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
All Rights Reserved, Duke Medicine 2008 Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does It Predict Mortality? Paul L. Hess, MD; Linda.
Current Quality of Cardiovascular Prevention for Million Hearts™ An Analysis of 147,038 Outpatients from The Guideline Advantage ™ Zubin J. Eapen, MD,
Fonarow GC, et al. J Am Coll Cardiol. 2007;50:768 777. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized.
Ethnic Differences in the Prognostic Value of Coronary Artery Calcification for All-Cause Mortality Khurram Nasir MD MPH, Leslee J. Shaw PhD, Sandy T.
M. JESSUP Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
© 2010, American Heart Association. All rights reserved. Hospital Performance Recognition with the Get with the Guidelines Program and Mortality for Acute.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
Regional Differences in Quality of Care and Outcomes for the Treatment of Acute Coronary Syndromes: An Analysis from the Get With The Guidelines Program.
Risks of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with Intravenous Tissue Plasminogen Activator.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
Acknowledgements Contact Information Anthony Wong, MTech 1, Senthil K. Nachimuthu, MD 1, Peter J. Haug, MD 1,2 Patterns and Rules Vital signs medoids.
Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography.
Interobserver Reliability of Acute Kidney Injury Network (AKIN) criteria A single center cohort study Figure 2 The acute kidney injury network (AKIN) criteria.
Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank.
© 2010, American Heart Association. All rights Association of Hospital Primary Angioplasty Volume in ST-Segment Elevation Myocardial Infarction With Quality.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
Sumeet Subherwal, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, Tracy Y. Wang, W. Brian Gibler, E. Magnus Ohman, Matthew T. Roe, Eric D.
Ian Graham et al. European Heart Journal 2007;28:
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Use of Hydralazine-Isosorbide Dinitrate combination in African American and Other Race/Ethnic Group Patients with Heart Failure and Reduced Ejection Fraction.
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
The long-term outcome after acute renal failure Presented by Ri 顏玎安.
CR-1 Candesartan in HF Benefit/Risk James B. Young, MD Cleveland Clinic Foundation.
Kelley M. Anderson, PhD, FNP
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Heart rate in heart failure: Heart rate in heart failure: risk marker or risk factor? A subanalysis of the SHIFT trial on behalf of the Investigators M.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Introduction Device infection remains a significant cause of morbidity and mortality in patients supported by mechanical assist devices. The infection.
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Fonarow GC et al. J Am Coll Cardiol 2007; 49(19):
© 2017 SlidePlayer.com Inc. All rights reserved.